Organogenesis Holdings (ORGO) Cash & Current Investments (2015 - 2026)
Organogenesis Holdings (ORGO) posted quarterly Cash & Current Investments of $92.1 million for Q1 2026, down 16.68% year-over-year from $110.5 million in Q1 2025, and down 2.37% quarter-over-quarter from $94.3 million in Q4 2025.
Organogenesis Holdings (ORGO) Cash & Current Investments (2015 - 2026) Analysis & Trends
Organogenesis Holdings' Cash & Current Investments history runs 12 years deep, the most recent figure standing at $92.1 million for Q1 2026.
- In Q1 2026, Cash & Current Investments fell 16.68% year-over-year to $92.1 million; the TTM figure through Mar 2026 stood at $92.1 million (down 16.68% YoY), while the FY2025 annual figure was $94.3 million, down 30.72% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $92.1 million, down from $94.3 million in the prior quarter.
- The five-year high for Cash & Current Investments was $136.2 million in Q4 2024, with the low at $64.4 million in Q3 2025.
- The 5-year median for Cash & Current Investments is $94.9 million (2024), against an average of $97.7 million.
- The sharpest annual moves came in 2022 and 2025: Cash & Current Investments soared 22080.9% in 2022, then plunged 32.19% in 2025.
- Organogenesis Holdings' Cash & Current Investments stood at $103.3 million in 2022, then advanced by 1.01% to $104.3 million in 2023, then soared by 30.49% to $136.2 million in 2024, then tumbled by 30.72% to $94.3 million in 2025, then slipped by 2.37% to $92.1 million in 2026.
- Business Quant data shows ORGO's Cash & Current Investments at $92.1 million in Q1 2026, $94.3 million in Q4 2025, and $64.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 963.33 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.66 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 5.80 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 164.00 Mn |
| 10 | Organogenesis Holdings | 238.69 Mn | 191.85 Mn | 20.08 Mn | 46.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 46.84 Mn |
| Mar 31, 2026 | 92.10 Mn |
| Dec 31, 2025 | 94.33 Mn |
| Sep 30, 2025 | 64.37 Mn |
| Jun 30, 2025 | 73.74 Mn |
| Mar 31, 2025 | 110.53 Mn |
| Dec 31, 2024 | 136.15 Mn |
| Sep 30, 2024 | 94.93 Mn |
| Jun 30, 2024 | 90.48 Mn |
| Mar 31, 2024 | 89.35 Mn |
| Dec 31, 2023 | 104.34 Mn |
| Sep 30, 2023 | 98.83 Mn |
| Jun 30, 2023 | 89.51 Mn |
| Mar 31, 2023 | 89.42 Mn |
| Dec 31, 2022 | 103.29 Mn |
| Sep 30, 2022 | 108.02 Mn |
| Jun 30, 2022 | 112.94 Mn |
| Mar 31, 2022 | 108.50 Mn |
| Dec 31, 2021 | 114.53 Mn |
| Sep 30, 2021 | 487,000.00 |